Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin
Phase of Trial: Phase 0
Latest Information Update: 14 Dec 2016
Price : $35 *
At a glance
- Drugs Daptomycin (Primary) ; Rifampicin
- Indications Bacteraemia; Bacterial endocarditis; Osteomyelitis; Skin and soft tissue infections; Staphylococcal infections
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 24 Oct 2016 Status changed from active, no longer recruiting to completed.
- 03 Dec 2015 Planned End Date changed from 1 Oct 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.